Soleno Therapeutics, Inc. (NASDAQ:SLNO) has achieved a major regulatory milestone as the European Medicines Agency (EMA) ...

Michael Dong recently discussed sample preparation (SP) techniques for small-molecule drug substances and solid dosage forms.

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg (Niaspan ...

Zydus Lifesciences Ltd on Wednesday received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets USP in 500 mg, 750 mg and ...

Zydus Lifesciences Limited, a major Indian pharmaceutical company, has secured final approval from the United States Food and Drug Administration (USFDA) to produce Niacin Extended-Release Tablets.

Zydus Lifesciences rose 1.02% to Rs 897 after the pharma company received final approval from the US Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets USP, 500 mg , ...

Ahmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release ...

“The court therefore declines to stay its order pending appeal and instead requires Mr. Mahdawi’s immediate release.” The judge, however, did provide some conditions for his releas ...